iShares U.S. Healthcare ETF News - June 10, 2026

GSK acquires Nuvalent for $10.6B, targeting blockbuster lung cancer drugs

GSK signed a definitive agreement to acquire Nuvalent for $10.6 billion. The transaction secures a portfolio of next-generation precision cancer therapies and...